The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas

Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar

NCT07137052 ·Status: NOT_YET_RECRUITING

PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach)

NCT02862028 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

NCT05602415 ·Status: UNKNOWN ·Phase: PHASE2

A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma

NCT07342322 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors

NCT07319767 ·Status: COMPLETED

A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors

NCT06612840 ·Status: RECRUITING ·Phase: PHASE1

Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)

NCT04892498 ·Status: UNKNOWN ·Phase: PHASE2

An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis

NCT05438342 ·Status: UNKNOWN ·Phase: NA

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

NCT02801487 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Trop-2 Targeted PET Probes in Advanced TNBC

NCT07046455 ·Status: RECRUITING ·Phase: NA

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

NCT04843709 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617

NCT04801264 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

NCT06465017 ·Status: TERMINATED ·Phase: NA

Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT05861557 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

NCT07258147 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

NCT04143984 ·Status: RECRUITING ·Phase: PHASE2

Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC

NCT03601390 ·Status: COMPLETED

A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors

NCT06101082 ·Status: RECRUITING ·Phase: PHASE1

Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy

NCT03689556 ·Status: UNKNOWN

68Ga-GP-01 Injection in Solid Tumors Participants

NCT07045428 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors

NCT04977128 ·Status: UNKNOWN ·Phase: NA

RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors

NCT05122572 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety of CRT, Durvalumab and Surgery for SST

NCT04465968 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC

NCT02978196 ·Status: COMPLETED ·Phase: EARLY_PHASE1

U87 CAR-T in Patients With Advanced Head and Neck Tumors

NCT06614686 ·Status: RECRUITING ·Phase: PHASE1